Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials


According to statistics, osteoarthritis affects roughly 22% to 39% of the population in India, making it the most common joint disease and the second most common rheumatologic problem in the country. Image used for representational purposes only

According to statistics, osteoarthritis affects roughly 22% to 39% of the population in India, making it the most common joint disease and the second most common rheumatologic problem in the country. Image used for representational purposes only
| Photo Credit: Getty Images/iStockphoto

In a study published in the New England Journal of Medicine, researchers in the U.S., Canada, Australia and the United Kingdom, showed that treatment with the drug retatrutide, may be useful for the treatment of painful knee arthritis in people with obesity. 

In two phase 3 trials, adults without diabetes who had painful knee osteoarthritis and a body mass index (BMI) of at least 27 were randomly assigned to receive once-weekly subcutaneous retatrutide.   

  • Related Posts

    Potent perovskites demand India make domestic manufacturing push

    A perovskite solar cell. | Photo Credit: Public domain Perovskite solar cells are an exciting technology in the solar industry because they extract more power from a given area than…

    Continue reading
    There is more to vanilla than its taste and aroma

    The vanilla flower belongs to the orchid family. | Photo Credit: File photo Vanilla is a common additive to make cakes, ice creams, and fragrant body lotions. Children enjoy a…

    Continue reading